MIAMI--(BUSINESS WIRE)--OPKO Health, Inc. (NYSE:OPK) will announce top line data from the first of two identical pivotal Phase 3 clinical trials for RAYALDEE™ and its second-quarter 2014 financial results on Monday, August 11, 2014, after the market closes. OPKO’s senior management team will host a conference call and live audio webcast at 8:30 a.m. ET on Tuesday, August 12, 2014 to discuss the Phase 3 data and the Company’s results in greater detail.
The conference call will be available via phone and webcast. The conference call dial-in information is listed below. To access the webcast, please log on to the OPKO website at www.opko.com at least 15 minutes prior to the start of the call to ensure adequate time for any software downloads that may be required. A link to the live webcast is also included below.
Help employers find you! Check out all the jobs and post your resume
